Drug Trial Radar · NCT04924322
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
258
Planned (sponsor's estimate)
Start
May 11, 2022
Primary completion
Apr 30, 2027
Study completion Aug 31, 2027
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Children's Hospital Colorado; Children's Hospital of Philadelphia; BJC HealthCare; Medical College of Wisconsin; Children's of Alabama; Golisano Children's Hospital; Maria Fareri Children's Hospital; Nationwide Children's Hospital; New York Presbyterian Hospital; Penn State University; University of Iowa; Johns Hopkins All Children's Hospital; University of Oklahoma; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Children's Hospital of Illinois at Peoria; Hassenfeld Children's Hospital
- First posted
- Jun 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Conditions
- Deep Venous Thrombosis
Interventions
EnoxaparinDrug
Enoxaparin is a LMWH produced from UFH that exerts its anticoagulant effects by binding to and inducing a conformational change in antithrombin to accelerate the inactivation of factor Xa and thrombin. Age-specified dose of enoxaparin will be administered within 24 hours after insertion of the CVC with the dose subsequently adjusted to pre-specified anti-Xa target.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of children with CADVTTime frame: Up to removal of CVC (maximum of 28 days)
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Children's of Alabama
Birmingham, Alabama · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Yale-New Haven Children's Hospital
New Haven, Connecticut · Recruiting
University of Florida -UF Health
Gainesville, Florida · Recruiting
Johns Hopkins All Children's
St. Petersburg, Florida · Recruiting
Children's Hospital of Illinois at OSF Saint Francis Medical Center
Peoria, Illinois · Recruiting
Stead Family Children's Hospital
Iowa City, Iowa · Recruiting
Children's Hospital St. Louis
St Louis, Missouri · Recruiting
Hassenfeld Children's Hospital
New York, New York · Recruiting
New York Presbyterian Hospital
New York, New York · Recruiting
Golisano Children's Hospital
Rochester, New York · Recruiting
Maria Fareri Children's Hospital
Valhalla, New York · Recruiting
UH Rainbow Babies & Children's Hospital
Cleveland, Ohio · Recruiting
Nationwide Children's Hospital
Columbus, Ohio · Withdrawn
University of Oklahoma
Oklahoma City, Oklahoma · Recruiting
Penn State Hershey Children's Hospital
Hershey, Pennsylvania · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Dell Children's Medical Canter
Austin, Texas · Recruiting
UTSW Medical Center; Children's Medical Center of Dallas
Dallas, Texas · Recruiting
Children's Hospital of Richmond
Richmond, Virginia · Withdrawn
Children's Hospital Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.